Volume 26, Issue 3 - Observational Studies

Guidelines for disclosing the results from observational trials

Authors: Andrea Rossi, Carla Benci, Phil Leventhal

Abstract

Download the full article

References

1. Altman DG. Practical statistics for medical research. London, UK: Chapman & Hall; 1991. Available from: http://
2. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996;312:1215–8. Available from: http://
3. Lauer MS, D’Agostino RB, Sr. The randomized registry trial – the next disruptive technology in clinical research? N Engl J Med 2013;369:1579–81. Available from: http://
4. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. Strength - ening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806–8. Available from: http://
5. Pocock SJ, Collier TJ, Dandreo KJ, de Stavola BL, Goldman MB, Kalish LA et al. Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ 2004;329:883. Available from: http://
6. Lee W, Bindman J, Ford T, Glozier N, Moran P, Stewart R, Hotopf M. Bias in psychiatric case-control studies: literature survey. Br J Psychiatry 2007;190:204–9. Available from: http://
7. Tooth L, Ware R, Bain C, Purdie DM, Dobson A. Quality of reporting of observational longitudinal research. Am J Epidemiol 2005;161:280–8. Available from: http://
8. Vandenbroucke JP, von Elm E, Altman DG et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 2007;18:805–35. Available from: http://
9. Golub RM, Fontanarosa PB. Researchers, readers, and reporting guidelines: writing between the lines. JAMA 2015; 313:1625-6. Available from: http://
10. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel–group randomised trials. Lancet 2001;357:{1191–4. Available from: http://
11. University of Bern. Translations of STROBE Statement. 2009 [cited 2017 Jun 2]. Available from: Available from: https://www.strobestatement.org/index.php?id=strobetranslations
12. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. The CARE guidelines: consensus–based clinical case report guide - line development. J Clin Epidemiol 2014;67:46–51. Available from: http://
13. Little J, Higgins JP, Ioannidis JP et al. STrengthening the REporting of Genetic Association studies (STREGA) – an extension of the STROBE statement. Eur J Clin Invest 2009;39:247–66. Available from: http://
14. Benchimol EI, Smeeth L, Guttmann A et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med 2015;12:e1001885. Available from: http://
15. Agha RA, Fowler AJ, Rajmohan S, Barai I, Orgill DP. Preferred reporting of case series in surgery; the PROCESS guidelines. Int J Surg 2016;36:319–23. Available from: http://
16. Rodgers M, Thomas S, Harden M, Parker G, Street A, Eastwood A. Developing a methodological framework for organisational case studies: a rapid review and consensus dev el - opment process. Southampton (UK), 2016. Available from: http://
17. Coroneos CJ, Ignacy TA, Thoma A. Designing and reporting case series in plastic surgery. Plast Reconstr Surg 2011;128:361e–8e. Available from: http://
18. Rubino M, Pragnell MVC. Guidelines for reporting case series of tumours of the colon and rectum. Tech Coloproct 1999;3:93–7. Available from: http://
19. Kempen JH. Appropriate use and reporting of uncontrolled case series in the medical literature. Am J Ophthalmol 2011;151: 7–10 e1. Available from: http://
20. White A. Conducting and reporting case series and audits – author guidelines for acupuncture in medicine. Acupunct Med 2005;23:181–7. Available from: http://
21. Lavergne V, Ouellet G, Bouchard J et al. Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology. Semin Dial 2014;27:407–14. Available from: http://
22. Eysenbach G. Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E–Surveys (CHERRIES). J Med Internet Res 2004;6:e34. Available from: http://
23. Burns KE, Duffett M, Kho ME, Meade MO, Adhikari NK, Sinuff T, Cook DJ. A guide for the design and conduct of self– administered surveys of clinicians. CMAJ 2008;179:245–52. Available from: http://
24. Agarwal S, LeFevre AE, Lee J et al. Guidelines for reporting of health interventions using mobile phones: mobile health (mHealth) evidence reporting and assessment (mERA) checklist. BMJ 2016;352:i1174 Available from: http://
25. Kelley K, Clark B, Brown V, Sitzia J. Good practice in the conduct and reporting of survey research. Int J Qual Health Care 2003;15:261–6. Available from: http://
26. Gallo V, Egger M, McCormack V et al. STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement. PLoS Med 2011;8:e1001117. Available from: http://
27. Hollenbach JA, Mack SJ, Gourraud PA et al. A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement. Tissue Antigens 2011;78:333–44. Available from: http://
28. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Clin Invest 2011;41:1004–9. Available from: http://
29. Bruck K, Jager KJ, Dounousi E et al. Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review. Nephrol Dial Transplant 2016;31:680. Available from: http://
30. Bennett DA, Brayne C, Feigin VL et al. Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology. Eur J Epidemiol 2015;30:569–76. Available from: http://
31. Lachat C, Hawwash D, Ocke MC et al. Strengthening the Reporting of Observational Studies in Epidemiology– Nutritional Epidemiology (STROBE–nut): An Extension of the STROBE Statement. PLoS Med 2016;13:e1002036. Available from: http://
32. Stevens GA, Alkema L, Black RE et al. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. Lancet 2016;388:e19–e23. Available from: http://
33. Fitchett EJ, Seale AC, Vergnano S et al. Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. Lancet Infect Dis 2016;16:e202–13. Available from: http://
34. Tacconelli E, Cataldo MA, Paul M et al. STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship. BMJ Open 2016;6:e010134. Available from: http://
35. Field N, Cohen T, Struelens MJ et al. Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement. Lancet Infect Dis 2014;14:341–52. Available from: http://
36. Stone SP, Cooper BS, Kibbler CC et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrob Chemother 2007;59:833–40. 28 | September 2017 Medical Writing | Volume 26 Number 3 Guidelines for disclosing the results from observational trials – Rossi et al Available from: http://
37. Horby PW, Laurie KL, Cowling BJ et al. CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement. Influenza Other Respir Viruses 2017;11:2–14. Available from: http://
38. Zavada J, Dixon WG, Askling J. Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries. Ann Rheum Dis 2014;73:628. Available from: http://
39. Dixon WG, Carmona L, Finckh A et al. EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology. Ann Rheum Dis 2010;69:1596–602. Available from: http://
40. Moore CM, Giganti F, Albertsen P et al. Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations- A Report of a European School of Oncology Task Force. Eur Urol 2017;71:648–55. Available from: http://
41. Moore CM, Kasivisvanathan V, Eggener S et al. Standards of reporting for MRI–targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol 2013;64:544–52. Available from: http://
42. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 2005;93:387–91. Available from: http://
43. Hlatky MA, Greenland P, Arnett DK et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009;119:2408–16. Available from: http://
44. Quintana DS, Alvares GA, Heathers JA. Guidelines for Reporting Articles on Psychiatry and Heart rate variability (GRAPH): recommendations to advance research communication. Transl Psychiatry 2016;6:e803. Available from: http://
45. Wardlaw JM, Smith EE, Biessels GJ et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822–38. Available from: http://
46. Creinin MD, Chen MJ. Medical abortion reporting of efficacy: the MARE guidelines. Contraception 2016;94:97–103. Available from: http://
47. Rosenthal R, Hoffmann H, Clavien PA, Bucher HC, Dell-Kuster S. Definition and Classification of Intraoperative Complications (CLASSIC): Delphi Study and Pilot Evaluation. World J Surg 2015;39:1663–71. Available from: http://
48. Bordeianu CD, Ticu CE. A new manner of reporting pressure results after glaucoma surgery. Clin Ophthalmol 2012;6:23–31. Available from: http://
49. Brethauer SA, Kim J, el Chaar M et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis 2015;11:489–506. Available from: http://
50. Sun BC, Thiruganasambandamoorthy V, Cruz JD. Standardized reporting guidelines for emergency department syncope riskstratification research. Acad Emerg Med 2012;19:694–702. Available from: http://
51. Bradt DA, Aitken P. Disaster medicine reporting: the need for new guidelines and the CONFIDE statement. Emerg Med Australas 2010;22:483–7. Available from: http://
52. Smith SM, Hunsinger M, McKeown A et al. Quality of pain intensity assessment reporting: ACTTION systematic review and recommendations. J Pain 2015; 16:299– 305. Available from: http://
53. Dionne CE, Dunn KM, Croft PR et al. A consensus approach toward the standardization of back pain definitions for use in prevalence studies. Spine (Phila Pa 1976) 2008;33:95–103. Available from: http://
54. Jason LA, Unger ER, Dimitrakoff JD et al. Minimum data elements for research reports on CFS. Brain Behav Immun 2012;26:401–6. Available from: http://
55. Leech NL, Onwuegbuzie AJ. Guidelines for conducting and reporting mixed research in the field of counseling and beyond. J Couns Dev 2010;88:61–9. Available from: http://
56. Crawford JR, Garthwaite PH, Porter S. Point and interval estimates of effect sizes for the case-controls design in neuropsychology: rationale, methods, implementations, and proposed reporting standards. Cogn Neuropsychol 2010;27:245–60. Available from: http://
57. Singh JP, Yang S, Mulvey EP. Reporting guidance for violence risk assessment predictive validity studies: the RAGEE Statement. Law Hum Behav 2015;39:15–22. Available from: http://
58. Kearon C, Iorio A, Palareti G. Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting. J Thromb Haemost 2010;8:2313–5. Available from: http://
59. Meyers PM, Schumacher HC, Higashida RT et al. Reporting standards for endovascular repair of saccular intracranial cerebral aneurysms. J Neurointerv Surg 2010;2: 312–23. Available from: http://
60. Wu T, Shang H, Bian Z, Zhang J, Li T, Li Y, Zhang B. Recommendations for reporting adverse drug reactions and adverse events of traditional Chinese medicine. J Evid Based Med 2010;3:11–7. Available from: http://
61. Melby MK, Sievert LL, Anderson D, Obermeyer CM. Overview of methods used in cross-cultural comparisons of menopausal symptoms and their determinants: Guidelines for Strengthening the Reporting of Menopause and Aging (STROMA) studies. Maturitas 2011;70:99–109. Available from: http://
62. Higginson IJ, Evans CJ, Grande G et al. Evaluating complex interventions in end of life care: the MORECare statement on good practice generated by a synthesis of transparent expert consultations and systematic reviews. BMC Med 2013;11:111. Available from: http://
63. Gershman MD, Staples JE, Bentsi-Enchill AD et al. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunisation safety data. Vaccine 2012;30:5038–58. Available from: http://
64. Sargeant JM, O’Connor AM, Dohoo IR et al. Methods and processes of developing the strengthening the reporting of observational studies in epidemiology – veterinary (STROBE-Vet) statement. Prev Vet Med 2016;134:188–96. Available from: http://
65. Cheng A, Kessler D, Mackinnon R et al. Reporting Guidelines for Health Care Simulation Research: Extensions to the CONSORT and STROBE Statements. Simul Healthc 2016;11:238–48. Available from: http://
66. White RG, Hakim AJ, Salganik MJ et al. Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: “STROBE-RDS” statement. J Clin Epidemiol 2015;68:1463–71. Available from: http://
67. Schriger DL. Suggestions for improving the reporting of clinical research: the role of narrative. Ann Emerg Med 2005;45:437–43. Available from: http://
68. Hrynaszkiewicz I, Norton ML, Vickers AJ, Altman DG. Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers. BMJ 2010;340:c181. Available from: http://
69. Olson SH, Voigt LF, Begg CB, Weiss NS. Reporting participation in case–control studies. Epidemiology 2002;13:123–6. Available from: http://
70. Brookhart MA, Rassen JA, Schneeweiss S. Instrumental variable methods in comparative safety and effectiveness research. Pharmacoepidemiol Drug Saf 2010;19:537–54. Available from: http://